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1. Introduction 
Furosemide (Fu) chemical name is 5-(aminosulfonyl)-4-chloro-2-[(2-furanyl methyl)amino)benzoic acid]. It has 
the following generic names: Frusemide, Fursemide, Aisemide, Beronald, Desdimin, Lasilix and others. The empirical 
formula is C12H11ClN2O5S corresponds to molecular weight of 330.77. Furosemide is white to slightly yellow, odourless, 
almost tasteless crystalline powder, slightly soluble in water, chloroform and ether soluble in acetone, methanol, dimethyl 
formamide [1] and in solutions of alkali hydroxides [2]. It melting point is 206°C, the pH of the aqueous solution is in the 
range 8.9 to 9.3. The UV spectrum of furosemide (0.01 mg/ml) in 0.1N NaOH was scanned from 190 to 400 nm using 
DMS 90 Varian spectrophotometer. It exhibited two maxima at 226 and 272 nm. Several methods have been reported for 
the determination of the components of this important drug (furosemide). Titrimetric methods [3-7] potentiometric methods 
[8,9]
 Ultraviolet methods, Colorimetric methods. Because of cost-effective and minimal maintenance, UV spectrophotometry 
is always preferred at small scale industries. Literature survey reveals that so far many UV spectrophotometric methods 
have been reported for the estimation of Furosemide in alone or in combination with other drugs [9]. But out of them only 
few methods included single estimation of furosemide. Therefore the main objective of the proposed methods were to 
develop simple, new and economic UV spectrophotometric methods for the estimation of furosemide  in bulk and tablet 
dosage form and validate as per ICH guidelines
.
 
Abstract 
The present work was to develop two simple UV spectrophotometric 
methods for simultaneous estimation of furosemide (FUR) in bulk and tablet 
dosage form and validate as per ICH guidelines. Method A is absorption 
maxima method in which λmax was found to be 277 nm. Method B is area 
under the curve (AUC) in which area in the wavelength range of 258.40 nm – 
293.80 nm was selected for analysis of furosemide. Linearity was observed in 
the concentration range 5-25μg/ml (r2 =0.999) for both the methods. The % 
assay for the marketed formulation for absorption maxima and area under the 
curve method was found to be 99.16%, and 99.20% respectively. The methods 
were validated with respect to linearity, precision and accuracy studies. 
Recovery studies for absorption maxima, and area under the curve was found 
to be 100.46%, and 100.86% respectively.  The developed methods were 
validated for linearity, precision, accuracy, LOD and LOQ as per ICH 
guidelines. Both the methods were found to be linear within the conc. Range of 
5-25μg/ml for furosemide. The present methods were found to be simple, 
linear, precise, accurate and sensitive and can be used for routine quality 
control analysis for the estimation of furosemide in bulk and tablet dosage 
form. 
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Furosemide 
2. Materials and Methods 
2.1 Chemicals 
Furosemide was supplied by Sanofi Aventis Andhari Mumbai, India. Tablet of furosemide 10mg (lasix) was 
procured from local pharmacy. Methanol S.D. Fine Chemicals, Mumbai, India) was used. All chemicals and reagents were 
of analytical reagent (AR) grade. 
2.2 Instrumentation 
A Shimadzu (Kyoto, Japan) model UV-1800 double beam UV-Visible spectrophotometer attached with computer 
operated software UV probe 2.0 with spectral width of 2 nm, wavelength accuracy of 0.5 nm and pair of 1 cm matched 
quartz cells was used to measure absorbance of the resulting solutions. Analytical balance, Mettler Toledo (Model JL1503-
C). 
2.3 Method 
2.3.1 UV-Spectroscopy Methods  
A) Absorbance Maxima Method [11] 
Ultraviolet-visible spectroscopy or ultraviolet-visible spectrophotometry (UV-Vis or UV/Vis) refers to absorption 
spectroscopy or reflection spectroscopy in the ultra visible spectral region. This means it uses light in the visible and 
adjacent (near-UV and near-infrared (NIR) ranges. The absorption or reflectance in the visible range directly affects the 
perceived color of the chemicals involved. In this region of the electromagnetic spectrum, molecules undergo electronic 
transitions. This technique is complementary to fluorescence spectroscopy, in that fluorescence deals with transitions from 
the excited state to the ground state, while absorption measures transitions from the ground state to the excited state.[11]
 
 
Figure 1: Absorbance maxima of the drug 
B) Area under curve method  
The AUC (area under curve) method is applicable where there is no sharp peak or when broad spectra are 
obtained. It involves the calculation of integrated value of absorbance with respect to the wavelength between the two 
selected wavelengths λ1 and λ2. Area calculation processing item calculates the area bound by the curve and the horizontal 
axis [14]. The horizontal axis is selected by entering the wavelength range over which area has to be calculated. This 
wavelength range is selected on the basis of repeated observation so as to get the linearity between area under curve and 
concentration. The above mentioned spectrums were used to calculate AUC. Thus, the calibration curve can be constructed 
by plotting concentration versus AUC [15]. 
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Figure 2: Area under curve shown in yellow colour of the drug 
2.4 Experimental Work 
a) To check the solubility of Furosemide 
10 mg of furosemide was weighed and solubility of this sample was checked in double distilled water, methanol, 
ethanol, 1N NaOH, acetonitrile 0.1N HCL. The drug was found to be soluble in methanol was selected.[16] 
b) To identify the λmax of furosemide  
10 mg of the pure drug was accurately weighed and dissolved in 10ml methanol and the volume was made up to 
10 ml with methanol to give a standard stock solution of 1000 μg/ml. Further 1000ppm withdrawn 2.5ml of  Aliquote 
diluted to 25 ml of volumetric flask and prepare 100 ppm and Suitable dilutions were made with distilled  water to get 
standard solutions of concentration:  5,10,15,20,25 μg/ml. 
 
Figure 3: Standard solution of 15μg/ml 
C) Sample preparation for analysis of Tablet formulation 
Twenty tablets (furosemide) containing 10 mg of furosemide weighed, average weight calculated and triturated to 
fine powder and then weight equivalent 10 mg of furosemide transferred to 10 ml of volumetric flask containing proposed 
diluent, then sonicated for 15 minutes and filtered through Whatman filter paper no. 42 to form 1000μg/ml of furosemide 
stock solution of and final volume made upto mark with diluent. From this, 2.5 ml of aliquot transferred in 25 ml of 
volumetric flask containing diluent to form 100μg/ml of furosemide stock solution and further dilution of 5, 10, 15, 20, 
25ppm and scanned in the range of 200-400 nm against methanol as blank at 277 nm and then drug content of solution was 
calculated by using standard calibration curve.[17] 
2.5 Analytical Method Development 
1. Accuracy [20]: It is closeness of the result obtained to the true value. It is often expressed as per cent age recovery by 
analyzing known added amounts of analyte. Also it can be determined by applying the procedure to quantitatively prepared 
samples.[18] 
2. Precision: The precision of analytical procedure expresses closeness of agreement (degree of scatter) between a series of 
measurements obtained from multiple sampling of the same homogenous sample under prescribed conditions. It may be 
considered at three levels: repeatability, intermediate precision and reproducibility. It is expressed as standard deviation 
or coefficient of variation[19]. 
3. Linearity: The linearity of an analytical procedure is the interval between the upper and lower concentration of analyte 
in the sample for which it has been demonstrated that the analytical procedure is of precision, accuracy and linearity.[20]
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3. Results and Discussion 
Method A 
A] Absorbance Maxima Method 
Table 1: Calibration data of furosmide for absorbance maxima 
Concentration (μg/ml) Absorbance (Nm) 
5 0.1922 
10 0.5357 
15 0.8327 
20 1.133 
25 1.4018 
 
 
Figure 4: Calibration curve for furosemide 
 
 
Figure 5: Spectrum of furosemide for absorbance maxima (15μg/ml) 
 
 
Figure 6: Overlay spectra of furosemide (5-25 μg/ml) 
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Table no.2: Parameters from the Calibration curve 
Parameter Observations 
Calibration curve Linear 
Expression  Abs=A+B* conc or y=mx+c 
Factor A 0.060 
Factor B 0.080 
Coefficient(r2)        0.998 
 
Table 3: Analysis of pure drug 
Sr. No Amount Taken  
(μg/ml) 
Absorbance 
nm 
Amount of  Drug Found  
(μg/ml) 
%  
Amount Found 
1 15 0.5357 7.511 112.67 
2 15 0.5234 7.3067 109.6 
3 15 0.4555 6.16 92.5 
4 15 0.4675 6.375 95.625 
5 15 0.4876 6.71 100.65 
6 15 0.4354 5.84 87.6 
 
Table 4: Statistical evaluation of pure drug 
% Mean* ±S.D.* %RSD* ±S.E.* 
99.16 0.02 0.02 0.08 
*Average of six determination 
 
Step 3 Analysis of marketed formulation 
Tablets were procured from local market (lasix by Sanofi India Limited) and average weight was determined. The 
powder equivalent to 10mg of furosemide was weighed accurately and dissolved in 10ml of methanol and filtered using 
whatmann filter paper # 42. The filtrate was appropriately diluted with methanol to give standard stock solution of 
1000μg/ml. Further dilutions were made using distilled water 2.5 ml make 25 ml volumetric flask to give 100ppm and 
further dilution 5, 10, 15, 20, 25ppm. Absorbance was measured at 277 nm against standard solution. 
 
Table 5: Calibration curve of marketed tablet- 
Concentration Absorption 
5 0.0687 
10 0.1324 
15 0.1965 
20 0.2543 
25 0.3227 
 
 
Figure 7: Calibration curve of marketed formulation (5-25ppm) 
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Figure 8: Spectrum of furosemide marketed formulation for absorbance maxima (15μg/ml) 
 
 
Figure 9: Overlay spectra of furosemide (5-25 μg/ml) 
 
Table 6: Analysis of marketed formulation 
Sr. No 
Amount Taken  
(μg/ml) 
Absorbance 
(Nm) 
Amount of  Drug Found  
(μg/ml) 
%  
Amount Found 
1 15 0.0996 7.8 117 
2 15 0.0897 6.975 104.6 
3 15 0.0845 6.5 98.12 
4 15 0.0786 6.05 90.75 
5 15 0.0786 6.05 90.75 
6 15 0.0812 6.2 94 
 
Table 7: Statistical evaluation of marketed formulation 
% Mean* ±S.D.* %RSD* ±S.E.* 
99.20 1.54 1.554 0.54 
*Average of six determination 
 
Step 4-Validation 
The developed method was validated as per ICH guidelines. 
Linearity: The linearity of measurement was evaluated by analyzing different concentrations of the standard solution of 
furosemide. Beer’s law was obeyed in the concentration range 10-50μg/ml. The correlation coefficient was found to be 
0.999309. 
Precision: 100 mg of furosemide was weighed accurately and dissolved in 100ml of methanol. From the standard stock 
solution appropriate quantity of solution was taken to make further dilutions with methanol to give 10μg/ml. Absorbance 
was measured at 238nm against standard solution. This procedure was carried out 6 times. 
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Table 8: Analysis of inter-day precision 
Sr. No 
Amount taken 
(μg/ml) 
Amount of drug 
found (μg/ml) 
% 
Amount found 
1 15 10.0700 100.70 
2 15 9.9345 99.34 
3 15 10.2088 102.08 
4 15 10.04216 100.42 
5 15 9.9317 99.31 
6 15 9.9750 99.75 
 
Table 9: Analysis of intra-day precision 
Sr. No Amount taken 
(μg/ml) 
Amount of drug 
found (μg/ml) 
%  
Amount found 
1 15 10.02 100.70 
2 15 9.890 98.34 
3 15 10.00 100.08 
4 15 9.97 99.42 
5 15 10.020 100 
6 15 10.0040 100 
 
Table 10: Statistical evaluation of inter-day and intra-day precision studies 
Parameter % Mean* ± S.D. * %RSD * ±S.E.* 
Interday 100.26 1.0526 1.05 0.4297 
Intraday 99.84 0.4978 0.50 0.2032 
Accuracy:- 
Accuracy studies were carried out by standard addition method. Pure furosemide was added at different levels i.e. 
80%, 100% and 120% to drug sample present in tablet dosage form (100 mg furosemide in each tablet). 
Recovery studies:- 
Table 11: Results of recovery studies 
Level of recovery  
(%) 
Amount taken 
(μg/ml) 
Amount of std. added 
(μg/ml) 
Absorbance 
(nm) 
Total amount recovered 
(μg/ml) 
% 
Recovery 
80 10 8 0.3648 18.16 103.88 
80 10 8 0.3641 18.13 103.46 
80 10 8 0.3638 18.12 103.29 
100 10 10 0.3914 19.46 101.81 
100 10 10 0.3802 18.23 102.01 
100 10 10 0.3820 19.45 101.69 
120 10 12 0.4076 20.23 103.95 
120 10 12 0.4062 20.09 103.27 
120 10 12 0.4025 20.08 101.49 
 
Table 12: Statistical evaluation of recovery studies 
Level recovery %mean ±S.D.* %RSD* ±S.E.* 
80 103.54 0.67 0.65 0.38 
100 101.83 0.1616 0.16 0.093 
120 102.90 1.1494 1.14 0.6636 
*Average of three reading 
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METHOD B 
B) AREA UNDER CURVE:- 
Step 1-Preparation of Standard Stock Solution 
 
Figure 10:  spectra of furosemide for AUC (5-25 μg/ml) 
Table 13: Calibration data of furosemide for area under curve 
Concentration Area 
5 3.123 
10 6.342 
15 9.76 
20 12.87 
25 15.89 
 
 
Figure 11: Calibration curve for furosemide for AUC 
 
Table 14: Parameters from the Calibration curve 
Parameter Observations 
Calibration curve Linear 
Expression  Abs=A+B* conc or y=mx+c 
Factor A 0.641 
Factor B 0.021 
Coefficient(r2)        0.999 
  
Table 15: analysis of pure drug: 
Sr. No 
Amount Taken 
(μg/ml) 
AUC Amount of  Drug Found (μg/ml) 
%  
Amount Found 
1 15 3.1412 10.11 101 
2 15 3.1101 10.00 100 
3 15 3.901 9.980 99.80 
4 15 3.123 10.10 101 
5 15 3.897 9.87 98.87 
6 15 3.1567 10.12 101 
y = 0.641x - 0.021
R² = 0.999
0
5
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Table 16: Statistical evaluation of pure drug 
% Mean* ±S.D.* %RSD* ±S.E.* 
100.46 0.01 0.018 0.006 
*average of six determinations 
 
Step 3-Analysis of marketed formulation 
Table 17: Analysis of marketed formulation 
Sr. No 
Amount Taken 
(μg/ml) 
AUC 
Amount of  Drug Found  
(μg/ml) 
%  
Amount Found 
1 15 3.1876 10.24 104 
2 15 3.15 10.14 101 
3 15 3.1234 10.02 100 
4 15 3.09 9.99 99.9 
5 15 3.897 9.987 99.87 
6 15 3.124 10.021 100 
 
Table 18: Statistical evaluation of marketed formulation 
% Mean* ±S.D.* %RSD* ±S.E.* 
100.86 0.01 0.01 0.006 
*average of six determinations 
Step 4-Validation 
The developed method was validated as per ICH guidelines. 
Linearity: The linearity of measurement was evaluated by analyzing different concentrations of the standard solution of 
furosemide. The Beer’s law was obeyed in the concentration range 5-25μg/ml. The correlation coefficient was found to be 
0.999309. 
Precision: 100 mg of furosemide was weighed accurately and dissolved in 100ml of methanol to give concentration of 
1000μg/ml. From the standard stock solution appropriate quantity of solution was taken further dilutions were made with 
methanol to give 10μg/ml. AUC was measured in the range 258.40-293.80nm. This procedure was carried out 6 times. 
 
Table 19: Results of intra-day precision 
Sr. No 
Amount taken 
(μg/ml) 
Amount of drug 
found (μg/ml) 
% 
Amount found 
1 15 10.0700 100.70 
2 15 9.9345 99.34 
3 15 10.2088 102.08 
4 15 10.04216 100.42 
5 15 9.9317 99.31 
6 15 9.9750 99.75 
 
Table 20: Results of inter-day precision 
Sr. no 
Amount taken 
(μg/ml) 
Amount of drug 
found (μg/ml) 
% 
Amount found 
1 15 10.02 100.70 
2 15 9.890 98.34 
3 15 10.00 100.08 
4 15 9.97 99.42 
5 15 10.020 100 
6 15 10.0040 100 
 
Table 21: Statistical evaluation of inter-day and intra-day precision studies 
Parameter % Mean* ± S.D. * %RSD * ±S.E.* 
Interday 100.26 1.0526 1.05 0.4297 
Intraday 99.84 0.4978 0.50 0.2032 
*Average of six determinations 
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Accuracy 
Accuracy studies were carried out by standard addition method. Standard sample of furosemide was added at 
different levels i.e. 80%, 100% and 120% to drug sample present in tablet dosage form. 
Recovery studies 
To tablet stock solution in 3 different volumetric flask, aliquots of 8ml, 10ml and12ml of the standard stock 
solution were added, volume was made upto 10ml with water to give concentration of 18 μg/ml (80%),20(100%) and 
22(120%). Absorbance was determined at 277nm. Procedure was repeated 3 times for 80%, 100% and 120% for recovery 
studies. 
Table 22: Results of recovery studies 
Level of 
recovery  
(% ) 
Amount 
taken(μg/ml) 
Amount of std. Added 
(μg/ml) 
Area under curve 
Total amount recovered 
(μg/ml) 
% 
Recovery 
80 10 8 5.523 17.34 100.88 
80 10 8 5.545 17.35 100.46 
80 10 8 5.589 17.38 98.76 
100 10 10 6.2358 17. 100.56 
100 10 10 6.234 18.23 100.90 
100 10 10 6.298 19.45 100.90 
120 10 12 6.734 20.23 98 
120 10 12 6.785 20.09 100 
120 10 12 6.7098 20.08 99.45 
 
Table 23: Statistical evaluation of recovery studies 
Level recovery %mean ±S.D.* %RSD* ±S.E.* 
80 100.54 1.00 0.011 0.578 
100 100.83 0.05 0.56 0.0345 
120 99 0.75 6.33 0.43 
*average of six determinations  
 
4. Conclusions 
Simple UV spectrophotometric methods have been developed and validated for the determination of furosemide in 
bulk and tablet dosage form. The results of the validation parameters show that the UV spectrophotometric methods were 
found to be accurate, precise and sensitive. Because of cost-effective and minimal maintenance, the present UV 
spectrophotometric methods can be preferred at small scale industries and successfully applied and suggested for the 
quantitative analysis of furosemide in pharmaceutical formulations for QC, where economy and time are essential and to 
assure therapeutic efficacy. 
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